Literature DB >> 9822633

Cellular adhesion mediated by factor J, a complement inhibitor. Evidence for nucleolin involvement.

S Larrucea1, C González-Rubio, R Cambronero, B Ballou, P Bonay, E López-Granados, P Bouvet, G Fontán, M Fresno, M López-Trascasa.   

Abstract

Factor J (FJ) is a complement inhibitor that acts on the classical and the alternative pathways. We demonstrated FJ-cell interactions in fluid phase by flow cytometry experiments using the cell lines Jurkat, K562, JY, and peripheral blood lymphocytes. FJ bound to plastic plates was able to induce in vitro adhesion of these cells with potency equivalent to fibronectin. As evidence for the specificity of this reaction, the adhesion was blocked by MAJ2, an anti-FJ monoclonal antibody, and by soluble FJ. Attachment of the cells required active metabolism and cytoskeletal integrity. The glycosaminoglycans heparin, heparan sulfate, or chondroitin sulfates A, B, and C inhibited to varying degrees the binding of FJ to cells, as did treatment with chondroitinase ABC. In the search for a putative receptor, a protein of 110 kDa was isolated by affinity chromatography, and microsequence analysis identified this protein as nucleolin. Confocal microscopy evidenced the presence of nucleolin in cell membrane by immunofluorescence with monoclonal (D3) and polyclonal anti-nucleolin antibodies in Jurkat cells. The interaction FJ-nucleolin was evidenced by Western blot and enzyme-linked immunosorbent assay. Furthermore, purified nucleolin and D3 inhibited adhesion of Jurkat cells to immobilized FJ, suggesting that the interaction was specific and that nucleolin mediated the binding.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9822633     DOI: 10.1074/jbc.273.48.31718

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  26 in total

1.  Identification of nucleolin as a new L-selectin ligand.

Authors:  G Harms; R Kraft; G Grelle; B Volz; J Dernedde; R Tauber
Journal:  Biochem J       Date:  2001-12-15       Impact factor: 3.857

2.  Nuclear targeting by the growth factor midkine.

Authors:  Yoshihisa Shibata; Takashi Muramatsu; Makoto Hirai; Tatsuya Inui; Terutoshi Kimura; Hidehiko Saito; Lynn M McCormick; Guojun Bu; Kenji Kadomatsu
Journal:  Mol Cell Biol       Date:  2002-10       Impact factor: 4.272

3.  Cell surface nucleolin on developing muscle is a potential ligand for the axonal receptor protein tyrosine phosphatase-sigma.

Authors:  Daniel E Alete; Mark E Weeks; Ara G Hovanession; Muhamed Hawadle; Andrew W Stoker
Journal:  FEBS J       Date:  2006-09-21       Impact factor: 5.542

4.  Arachidonic acid stimulates formation of a novel complex containing nucleolin and RhoA.

Authors:  Melissa C Garcia; Jason Williams; Katina Johnson; Kenneth Olden; John D Roberts
Journal:  FEBS Lett       Date:  2011-02-01       Impact factor: 4.124

Review 5.  Discovery and development of the G-rich oligonucleotide AS1411 as a novel treatment for cancer.

Authors:  Paula J Bates; Damian A Laber; Donald M Miller; Shelia D Thomas; John O Trent
Journal:  Exp Mol Pathol       Date:  2009-01-20       Impact factor: 3.362

6.  Nucleolin mediates the binding of cancer cells to L-selectin under conditions of lymphodynamic shear stress.

Authors:  Tovë M Goldson; Kevin L Turner; Yinan Huang; Grady E Carlson; Emily G Caggiano; Andres F Oberhauser; Susan M Fennewald; Monica M Burdick; Vicente A Resto
Journal:  Am J Physiol Cell Physiol       Date:  2019-10-23       Impact factor: 4.249

7.  Ecto-protein kinase substrate p120 revealed as the cell-surface-expressed nucleolar phosphoprotein Nopp140: a candidate protein for extracellular Ca2+-sensing.

Authors:  D Kübler
Journal:  Biochem J       Date:  2001-12-15       Impact factor: 3.857

8.  Infection of macrophage-like THP-1 cells with Mycobacterium avium results in a decrease in their ability to phosphorylate nucleolin.

Authors:  R C Garcia; E Banfi; M G Pittis
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

9.  Regulatory effect of cinnamaldehyde on monocyte/macrophage-mediated inflammatory responses.

Authors:  Byung Hun Kim; Yong Gyu Lee; Jaehwi Lee; Joo Young Lee; Jae Youl Cho
Journal:  Mediators Inflamm       Date:  2010-05-11       Impact factor: 4.711

10.  Targeting surface nucleolin with a multivalent pseudopeptide delays development of spontaneous melanoma in RET transgenic mice.

Authors:  Diala El Khoury; Damien Destouches; Renée Lengagne; Bernard Krust; Yamina Hamma-Kourbali; Marylène Garcette; Sandra Niro; Masashi Kato; Jean-Paul Briand; José Courty; Ara G Hovanessian; Armelle Prévost-Blondel
Journal:  BMC Cancer       Date:  2010-06-24       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.